BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 36326951)

  • 21. Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.
    Weil R; Laplantine E; Curic S; GĂ©nin P
    Front Immunol; 2018; 9():1243. PubMed ID: 29971063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies.
    Schiavi A; Strappazzon F; Ventura N
    Mech Ageing Dev; 2020 Jun; 188():111252. PubMed ID: 32330468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions.
    Mani S; Swargiary G; Chadha R
    Mitochondrion; 2021 Mar; 57():270-293. PubMed ID: 33476770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitophagy in neurodegeneration: an opportunity for therapy?
    Santos RX; Correia SC; Carvalho C; Cardoso S; Santos MS; Moreira PI
    Curr Drug Targets; 2011 Jun; 12(6):790-9. PubMed ID: 21269269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.
    Moloudizargari M; Asghari MH; Ghobadi E; Fallah M; Rasouli S; Abdollahi M
    Ageing Res Rev; 2017 Nov; 40():64-74. PubMed ID: 28923312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomal degradation of depolarized mitochondria is rate-limiting in OPTN-dependent neuronal mitophagy.
    Evans CS; Holzbaur ELF
    Autophagy; 2020 May; 16(5):962-964. PubMed ID: 32131674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitophagy in neurological disorders.
    Zhang L; Dai L; Li D
    J Neuroinflammation; 2021 Dec; 18(1):297. PubMed ID: 34937577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms.
    Karbowski M; Oshima Y; Verhoeven N
    Cell Mol Life Sci; 2022 Oct; 79(11):574. PubMed ID: 36308570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal autophagy and mitophagy in Parkinson's disease.
    Lizama BN; Chu CT
    Mol Aspects Med; 2021 Dec; 82():100972. PubMed ID: 34130867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Mitophagy in Alzheimer's Disease.
    Jayatunga DPW; Hone E; Bharadwaj P; Garg M; Verdile G; Guillemin GJ; Martins RN
    J Alzheimers Dis; 2020; 78(4):1273-1297. PubMed ID: 33285629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy and Mitochondria: Targets in Neurodegenerative Disorders.
    Kumar A; Dhawan A; Kadam A; Shinde A
    CNS Neurol Disord Drug Targets; 2018; 17(9):696-705. PubMed ID: 30113005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation.
    Yamano K; Matsuda N; Tanaka K
    EMBO Rep; 2016 Mar; 17(3):300-16. PubMed ID: 26882551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
    Yao RQ; Ren C; Xia ZF; Yao YM
    Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System.
    Zhang H; Dai S; Yang Y; Wei J; Li X; Luo P; Jiang X
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unravelling mitochondrial pathways to Parkinson's disease.
    Celardo I; Martins LM; Gandhi S
    Br J Pharmacol; 2014 Apr; 171(8):1943-57. PubMed ID: 24117181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches.
    Yang X; Zhang Y; Luo JX; Zhu T; Ran Z; Mu BR; Lu MH
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3503-3528. PubMed ID: 37535076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitophagy links oxidative stress conditions and neurodegenerative diseases.
    Shefa U; Jeong NY; Song IO; Chung HJ; Kim D; Jung J; Huh Y
    Neural Regen Res; 2019 May; 14(5):749-756. PubMed ID: 30688256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.